Carregant...
Miniatura

Tipus de document

Article

Versió

Versió publicada

Data de publicació

Llicència de publicació

cc by-nc (c) Macdougall et al., 2020
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/173059

Iron Sucrose: A Wealth of Experience in Treating Iron Deficiency

Títol de la revista

Director/Tutor

ISSN de la revista

Títol del volum

Resum

Iron deficiency and iron-deficiency anemia are associated with increased morbidity and mortality in a wide range of conditions. In many patient populations, this can be treated effectively with oral iron supplementation; but in patients who are unable to take or who do not respond to oral iron therapy, intravenous iron administration is recommended. Furthermore, in certain conditions, such as end-stage kidney disease, chronic heart failure, and inflammatory bowel disease, intravenous iron administration has become first-line treatment. One of the first available intravenous iron preparations is iron sucrose (Venofer®), a nanomedicine that has been used clinically since 1949. Treatment with iron sucrose is particularly beneficial owing to its ability to rapidly increase hemoglobin, ferritin, and transferrin saturation levels, with an acceptable safety profile. Recently, important new data relating to the use of iron sucrose, including the findings from the landmark PIVOTAL trial in patients with end-stage kidney disease, have been reported. Several years ago, a number of iron sucrose similars became available, although there have been concerns about the clinical appropriateness of substituting the original iron sucrose with an iron sucrose similar because of differences in efficacy and safety. This is a result of the complex and unique physicochemical properties of nanomedicines such as iron sucrose, which make copying the molecule difficult and problematic. In this review, we summarize the evidence accumulated during 70 years of clinical experience with iron sucrose in terms of efficacy, safety, and cost-effectiveness.

Citació

Citació

MACDOUGALL, Iain c., COMÍN COLET, Josep, BREYMANN, Christian, SPAHN, Donat r., KOUTROUBAKIS, Ioannis e.. Iron Sucrose: A Wealth of Experience in Treating Iron Deficiency. _Advances in Therapy_. 2020. Vol. 37, núm. 5, pàgs. 1960-2002. [consulta: 31 de gener de 2026]. ISSN: 0741-238X. [Disponible a: https://hdl.handle.net/2445/173059]

Exportar metadades

JSON - METS

Compartir registre